Latest Bernstein Liebhard LLP Stories
The publication of the analysis echoes recent FDA concerns that prescription low testosterone treatments are being used extensively to relieve low hormone levels normally associated with male
Bernstein Liebhard LLP, which is currently representing a number of Xarelto plaintiffs in U.S.
NEW YORK, March 26, 2015 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether SanDisk Corp.
Case lists issued on March 21st indicates that 169 new vaginal mesh lawsuits have been filed over the past month in New Jersey’s Bergen County Superior Court, all of which allege pelvic mesh
Bernstein Liebhard LLP is representing numerous Risperdal plaintiffs in the Pennsylvania litigation, all of whom allegedly experienced excessive male breast growth due to their use of the antipsychotic
Court records updated on March 16, 2015 reflect the filing of nearly 2,100 Lipitor lawsuits in the U.S.
Bernstein Liebhard is currently filing claims in federal court on behalf of individuals who allegedly suffered serious cardiovascular injuries due to the blood thinning medication.
Bernstein Liebhard LLP is representing a number of testosterone lawsuit plaintiffs in this proceeding who experienced heart attacks, strokes and other cardiovascular complications, allegedly due
NEW YORK, March 19, 2015 /PRNewswire/ -- Another family has come forward to voice concerns about an alleged link between Zofran and birth defects (
The shift away from power morcellators to perform minimally-invasive hysterectomies and fibroid removal surgeries follows recent warnings from the FDA regarding the potential for the devices to
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.